Overview

INF108F in Infants With Food Protein Induced Proctocolitis

Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
Single-center, randomized, double-blind, placebo-controlled trail evaluating INF108F in breastfed infants with FPIAP
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital